Alerts will be sent to your verified email
Verify Email
MANKIND
|
Mankind Pharma
|
Dr. Reddy's Lab
|
Torrent Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Number of ANDA's Filed in USA
|
60.0 . | 361.0 . | 168.0 . |
|
Number of ANDA's Approved By USFDA
|
44.0 . | 288.0 . | 132.0 . |
|
Domestic Sales Growth - YoY
|
n/a | 11.1 % | 14.1 % |
|
R&D as a % of Total Sales
|
2.15 % | 8.5 % | 5.1 % |
|
Unclassified
|
|||
|
Advertisement Spend as a % of Total Sales
|
5.84 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
23.46 % | 14.9 % | 20.0 % |
|
5yr average Equity Multiplier
|
1.37 | 1.41 | 2.34 |
|
5yr Average Asset Turnover Ratio
|
0.95 | 0.77 | 0.65 |
|
5yr Avg Net Profit Margin
|
17.9 % | 14.03 % | 13.21 % |
|
Price to Book
|
7.29 | 3.05 | 14.66 |
|
P/E
|
51.21 | 18.07 | 58.24 |
|
5yr Avg Cash Conversion Cycle
|
-44.05 Days | 64.1 Days | -189.03 Days |
|
Inventory Days
|
58.78 Days | 75.39 Days | 54.5 Days |
|
Days Receivable
|
24.18 Days | 99.54 Days | 41.38 Days |
|
Days Payable
|
130.75 Days | 102.35 Days | 318.84 Days |
|
5yr Average Interest Coverage Ratio
|
56.97 | 34.06 | 5.79 |
|
5yr Avg ROCE
|
30.07 % | 19.83 % | 23.72 % |
|
5yr Avg Operating Profit Margin
|
24.6 % | 21.19 % | 29.52 % |
|
5 yr average Debt to Equity
|
0.05 | 0.12 | 0.83 |
|
5yr CAGR Net Profit
|
13.17 % | 22.45 % | 10.08 % |
|
5yr Average Return on Assets
|
17.12 % | 10.71 % | 8.58 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.7 % | 26.64 % | 68.31 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.8 % | -0.08 % | -2.94 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.84 % | -1.23 % | -2.45 % |
|
Mankind Pharma
|
Dr. Reddy's Lab
|
Torrent Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Acute vs Chronic
|
Acute vs Chronic
|
-
|
Acute vs Chronic
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|